Source: Monthly Prescribing Reference
Publication Date: May 4, 2018
FDA grants PaxVax Fast Track designation for vaccine to prevent against disease caused by chikungunya virus.
It’s an exciting time to join PaxVax. If you’re looking for an opportunity in healthcare to drive creativity, collaboration and innovation, we’d like to hear from you.